Australian scientists developed a novel antiviral that targets the SARS-CoV-2 PLpro enzyme, showing strong preclinical efficacy in reducing both acute and long COVID symptoms in mice.
Scientists stop long-COVID symptoms in mice using a new antiviral compound
- Post author:admin
- Post published:April 9, 2025
- Post category:uncategorized